HER2 has been reported to be highly expressed in parotid cancer (Cornolti et al, 2007; Williams et al, 2010), and lapatinib was reported to be effective for the treatment of parotid cancer in a phase I study (Burris et al, 2009). The gene discussed is ERBB2; the disease is parotid gland cancer.